Dupont Capital Management Corp Repligen Corp Transaction History

Dupont Capital Management Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$138.42 - $180.31 $44,709 - $58,240	-323 Reduced 7.27%	4,118 $582,000
Q1 2023 Apr 28, 2023	SELL	$154.26 - $198.1 $131,121 - $168,385	-850 Reduced 16.07%	4,441 $747,000
Q4 2022 Jan 26, 2023	SELL	$162.42 - $220.56 $65,130 - $88,444	-401 Reduced 7.04%	5,291 $0
Q3 2022 Oct 31, 2022	SELL	$160.42 - $256.21 $169,403 - $270,557	-1,056 Reduced 15.65%	5,692 $1.07 Million
Q2 2022 Jul 26, 2022	BUY	$140.68 - $188.02 $224,243 - $299,703	1,594 Added 30.93%	6,748 $1.1 Million
Q1 2022 Apr 27, 2022	SELL	$161.19 - $257.96 $328,182 - $525,206	-2,036 Reduced 28.32%	5,154 $969,000
Q4 2021 Jan 31, 2022	SELL	$247.59 - $304.47 $151,029 - $185,726	-610 Reduced 7.82%	7,190 $1.9 Million
Q3 2021 Nov 03, 2021	BUY	$194.77 - $324.21 $889,514 - $1.48 Million	4,567 Added 141.26%	7,800 $2.25 Million
Q1 2021 Apr 29, 2021	SELL	$180.37 - $226.26 $89,102 - $111,772	-494 Reduced 13.25%	3,233 $629,000
Q3 2020 Oct 29, 2020	SELL	$122.51 - $158.27 $52,434 - $67,739	-428 Reduced 10.3%	3,727 $550,000
Q2 2020 Jul 24, 2020	SELL	$94.33 - $140.48 $2,263 - $3,371	-24 Reduced 0.57%	4,155 $514,000
Q1 2020 Apr 29, 2020	SELL	$84.96 - $109.14 $369,491 - $474,649	-4,349 Reduced 51.0%	4,179 $403,000
Q4 2019 Jan 27, 2020	BUY	$73.84 - $93.08 $253,123 - $319,078	3,428 Added 67.22%	8,528 $789,000
Q3 2019 Oct 28, 2019	BUY	$76.65 - $95.51 $390,915 - $487,101	5,100 New	5,100 $391,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.